GENE ONLINE|News &
Opinion
Blog

2021-08-17| M&A

Booming Bioanalytical CRO Sets Sights on Australian Market with 360biolabs Acquisition

by Rajaneesh K. Gopinath
Share To
After establishing its footprint in the west, Durham-based BioAgilytix Labs is looking to broaden its presence on the other side of the world. On August 16th, the leading global contract research laboratory announced plans to buy Australian CRO 360biolabs for an undisclosed amount.

BioAgilytix is currently operating in two US locations; Durham, North Carolina, and Boston, Massachusetts. Besides, it also has a laboratory in Hamburg, Germany. With the latest acquisition of 360biolabs, the company aims to extend its services to customers in Melbourne, Victoria.

GO Prime with only $1.49 now

LATEST
35% Of Better Therapeutics’ Staff to be Cut to Extend the Company’s Runway
2023-03-27
Pharming’s Joenja Racks Up FDA Approval For Rare Primary Immunodeficiency
2023-03-27
Ways to Reduce Carbon Emission in Cement Manufacturing
2023-03-26
Moderna Injects $76 Million To Kickstart Lipid Nanoparticle Delivery Partnership With Generation Bio
2023-03-24
Shining a Light on Oncology with Rakuten Medical Co-CEO Takashi Toraishi
2023-03-23
Incyte’s Zynyz Secures FDA Approval for Treating a Rare and Aggressive Skin Cancer
2023-03-23
Biohaven Licenses TYK2/JAK1 Dual Inhibitor From China’s Highlight In $970 Million Pact
2023-03-23
Scroll to Top